Patient-Centered Customized Psychosocial Adherence Enhancement Intervention Schizophrenia (CAE-S) Study
Prospective 12-week randomized controlled trial (RCT) of remotely- delivered Customized Adherence Enhancement for poorly adherent individuals with schizophrenia (CAE-S) vs Enhanced Treatment as Usual (eTAU)
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Behavioral
- Trial Phase: NA
- Conditions Being Studied:
Study Purpose
The purpose of the study is to see if a behavioral intervention helps people who have schizophrenia take their medication more consistently and better manage their symptoms. Participating is the study lasts about 3 months and includes 3 study visits and 6 educational session visits. All visits can be done via video conferencing and compensation is provided.
Who Can Participate
Participants 18 years or older diagnosed with schizophrenia may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20230135
- StudyID: 2022-01101
- ClinicalTrials.gov: N/A
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422